Search Results - "SHOEMAKER, Alex R"

Refine Results
  1. 1
  2. 2

    ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo by Ackler, Scott, Xiao, Yu, Mitten, Michael J, Foster, Kelly, Oleksijew, Anatol, Refici, Marion, Schlessinger, Sally, Wang, Baole, Chemburkar, Sanjay R, Bauch, Joy, Tse, Christin, Frost, David J, Fesik, Stephen W, Rosenberg, Saul H, Elmore, Steven W, Shoemaker, Alex R

    Published in Molecular cancer therapeutics (01-10-2008)
    “…ABT-263 is a potent, orally bioavailable inhibitor of the antiapoptotic Bcl-2 family members Bcl-2, Bcl-x L , and Bcl-w, which is currently in phase I clinical…”
    Get full text
    Journal Article
  3. 3

    Hypoxia-Inducible Factor-1 Inhibition in Combination with Temozolomide Treatment Exhibits Robust Antitumor Efficacy In vivo by LEIMING LI, XIAOYU LIN, SHOEMAKER, Alex R, ALBERT, Daniel H, FESIK, Stephen W, YU SHEN

    Published in Clinical cancer research (01-08-2006)
    “…Purpose: Inhibiting hypoxia-inducible factor-1 (HIF-1) represents a unique mechanism for cancer therapy. It is conceived that HIF-1 inhibitors may synergize…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Tumor Regionality in the Mouse Intestine Reflects the Mechanism of Loss of Apc Function by Haigis, Kevin M., Hoff, Peter D., White, Alanna, Shoemaker, Alex R., Halberg, Richard B., Dove, William F.

    “…Inherited colorectal cancer syndromes in humans exhibit regional specificity for tumor formation. By using mice with germline mutations in the adenomatous…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    PARP inhibitors attenuate chemotherapy-induced painful neuropathy by Brederson, Jill-Desiree, Joshi, Shailen K., Browman, Kaitlin E., Mikusa, Joseph, Zhong, Chengmin, Gauvin, Donna, Liu, Xuesong, Shi, Yan, Penning, Thomas D., Shoemaker, Alex R., Giranda, Vincent L.

    Published in Journal of the peripheral nervous system (01-09-2012)
    “…Chemotherapy‐induced peripheral neuropathy (CIPN) is a major toxicity of chemotherapy treatment for which no therapy is approved. Poly(ADP‐ribose) polymerase…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A Resistant Genetic Background Leading to Incomplete Penetrance of Intestinal Neoplasia and Reduced Loss of Heterozygosity in ApcMin/+ Mice by Shoemaker, Alex R., Moser, Amy R., Midgley, Carol A., Clipson, Linda, Newton, Michael A., Dove, William F.

    “…Previous studies of Min/+ (multiple intestinal neoplasia) mice on a sensitive genetic background, C57BL/6 (B6), showed that adenomas have lost heterozygosity…”
    Get full text
    Journal Article
  11. 11

    N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice : age-related effects on the formation of intestinal adenomas : cystic crypts, and epidermoid cysts by SHOEMAKER, A. R, MOSER, A. R, DOVE, W. F

    Published in Cancer research (Chicago, Ill.) (01-10-1995)
    “…The timing of intestinal tumor initiation in B6-Min/+ mice has been examined by treating mice at 5-35 days of age with a single i.p. injection of the…”
    Get full text
    Journal Article
  12. 12

    Somatic mutational mechanisms involved in intestinal tumor formation in Min mice by SHOEMAKER, A. R, LUONGO, C, MOSER, A. R, MARTON, L. J, DOVE, W. F

    Published in Cancer research (Chicago, Ill.) (15-05-1997)
    “…We have demonstrated previously that intestinal tumor formation in B6 Min/+ mice is always accompanied by loss of the wild-type adenomatous polyoposis coli…”
    Get full text
    Journal Article
  13. 13

    Manipulation of the mouse germline in the study ofMin-induced neoplasia by Bilger, Andrea, Shoemaker, Alex R., Gould, Karen A., Dove, William F.

    Published in Seminars in cancer biology (01-10-1996)
    “…The Min mouse, generated by random germline mutagenesis, carries a mutation in the mouse homolog of APC and is a model of inherited human intestinal…”
    Get full text
    Journal Article
  14. 14

    Homozygosity for the Minallele of Apc results in disruption of mouse development prior to gastrulation by Moser, Amy Rapaich, Shoemaker, Alex R., Connelly, Camille S., Clipson, Linda, Gould, Karen A., Luongo, Cindy, Dove, William F., Siggers, Pamela H., Gardner, Richard L.

    Published in Developmental dynamics (01-08-1995)
    “…Mutation of the APC (adenomatous polyposis coli) gene is an early event in colon tumor development in humans. Mice carrying Min (multiple intestinal…”
    Get full text
    Journal Article
  15. 15

    The Bcl-2 Family Inhibitor ABT-263 Shows Significant Anti-Tumor Efficacy in Models of B Cell Non-Hodgkin's Lymphoma by Shoemaker, Alex R., Mitten, Michael J., Oleksijew, Anatol, O'Connor, Jacqeuline M., Wang, Baole, Ackler, Scott, Joseph, Mary, Zhang, Haichao, Nimmer, Paul, Xiao, Yu, Tse, Christin, Frost, David J., Fesik, Stephen W., Rosenberg, Saul H., Elmore, Steven W.

    Published in Blood (16-11-2006)
    “…ABT-263 is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins with a Ki of ≤ 1 nM against Bcl-2, Bcl-XL, and Bcl-w. Non-Hodgkin's B-cell…”
    Get full text
    Journal Article
  16. 16

    The Bcl-2 Family Inhibitor ABT-263 Shows Significant but Reversible Thrombocytopenia in Mice by Shoemaker, Alex R., Mitten, Michael J., Adickes, Jessica, Oleksijew, Anatol, Zhang, Haichao, Bauch, Joy, Marsh, Kennan, Frost, David J., Madar, David, Tse, Christin, Fesik, Stephen W., Rosenberg, Saul H., Elmore, Steven W.

    Published in Blood (16-11-2006)
    “…ABT-263 is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins with a Ki of ≤ 1 nM against Bcl-2, Bcl-XL, and Bcl-w. Potent cytotoxic…”
    Get full text
    Journal Article
  17. 17

    Mlh1 deficiency enhances several phenotypes of Apc(Min)/+ mice by Shoemaker, A R, Haigis, K M, Baker, S M, Dudley, S, Liskay, R M, Dove, W F

    Published in Oncogene (25-05-2000)
    “…Defects in APC and DNA mismatch repair genes are associated with a strong predisposition to colon cancer in humans, and numerous mouse strains with mutations…”
    Get full text
    Journal Article
  18. 18

    Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation by Moser, A R, Shoemaker, A R, Connelly, C S, Clipson, L, Gould, K A, Luongo, C, Dove, W F, Siggers, P H, Gardner, R L

    Published in Developmental dynamics (01-08-1995)
    “…Mutation of the APC (adenomatous polyposis coli) gene is an early event in colon tumor development in humans. Mice carrying Min (multiple intestinal…”
    Get full text
    Journal Article
  19. 19

    Manipulation of the mouse germline in the study of Min-induced neoplasia by Bilger, A, Shoemaker, A R, Gould, K A, Dove, W F

    Published in Seminars in cancer biology (01-10-1996)
    “…The Min mouse, generated by random germline mutagenesis, carries a mutation in the mouse homolog of APC and is a model of inherited human intestinal…”
    Get full text
    Journal Article
  20. 20

    A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in Apc Min /+ mice by Shoemaker, Alex R., Moser, Amy R., Midgley, Carol A., Clipson, Linda, Newton, Michael A., Dove, William F.

    “…Previous studies of Min /+ (multiple intestinal neoplasia) mice on a sensitive genetic background, C57BL/6 (B6), showed that adenomas have lost heterozygosity…”
    Get full text
    Journal Article